Document Detail


Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias.
MedLine Citation:
PMID:  12794630     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Malignant ventricular tachyarrhythmia (VT) and sudden death are serious events in hypertrophic cardiomyopathy (HCM). However, the pathophysiology of this condition is not well understood. The objective of this study was to evaluate the relationship between cardiac sympathetic nerve activity and the occurrence of VT in HCM patients. Methods and results We studied iodine 123 metaiodobenzylguanidine scintigraphy and 24-hour ambulatory electrocardiographic monitoring in 44 HCM patients, 15 with VT (group A) and 29 without VT (group B). With planar I-123 metaiodobenzylguanidine imaging, the heart-to-mediastinum ratio for early and delayed acquisition and washout rate were calculated. Polar maps of left ventricular myocardium were divided into 20 segments, and the SD of uptake and washout rate in 20 segments were calculated as indices of regional variation. The global washout rate was significantly higher in group A than in group B (26.8 +/- 6.4% vs 17.4 +/- 5.7%, P <.0001), although other parameters including heterogeneity indices did not differ. The logistic multiple regression analysis also determined that washout rate was the most powerful predictor of VT in patients with HCM.
CONCLUSIONS: The occurrence of malignant VT in HCM may be associated with global cardiac sympathetic nerve activity rather than with the heterogeneity of this activity.
Authors:
Hidenobu Terai; Masami Shimizu; Hidekazu Ino; Masato Yamaguchi; Kenshi Hayashi; Kenji Sakata; Masaru Kiyama; Tatsumi Hayashi; Masaru Inoue; Junichi Taki; Hiroshi Mabuchi
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology     Volume:  10     ISSN:  1071-3581     ISO Abbreviation:  J Nucl Cardiol     Publication Date:    2003 May-Jun
Date Detail:
Created Date:  2003-06-09     Completed Date:  2004-03-16     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  9423534     Medline TA:  J Nucl Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  304-10     Citation Subset:  IM    
Affiliation:
Molecular Genetics of Cardiovascular Disorders, Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan. terai-h@mug.biglobe.ne.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3-Iodobenzylguanidine / diagnostic use*
Adult
Aged
Cardiomyopathy, Hypertrophic / complications*,  physiopathology*,  radionuclide imaging
Electrocardiography, Ambulatory
Female
Humans
Male
Middle Aged
Radiopharmaceuticals / diagnostic use*
Regression Analysis
Sympathetic Nervous System / physiopathology,  radionuclide imaging*
Tachycardia, Ventricular / etiology*
Tomography, Emission-Computed, Single-Photon*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 77679-27-7/3-Iodobenzylguanidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gated fluorine 18 fluorodeoxyglucose positron emission tomography: determination of global and regio...
Next Document:  Structural and functional insights into PINCH LIM4 domain-mediated integrin signaling.